Park; Aeri

Patent Applications and Registrations

Patent applications and USPTO patent grants for Park; Aeri.The latest application filed is for "novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-p- yrrole-1-heptanoic acid calcium salt (2:1)".

Company Profile

0.9.18

Park; Aeri - Lansdale PA
Park; Aeri - West Lafayette IN US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20180009748 - Krzyzaniak; Joseph Francis ; et al.	2018-01-11
Forms of [R-(R,R)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-p- yrrole-1-heptanoic acid calcium salt (2:1) Grant 9,790,177 - Laurence , et al. October 17, 2	2017-10-17
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20170022156 - Krzyzaniak; Joseph Francis ; et al.	2017-01-26
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20160046575 - Krzyzaniak; Joseph Francis ; et al.	2016-02-18
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20150045563 - Krzyzaniak; Joseph Francis ; et al.	2015-02-12
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20140018546 - Krzyzaniak; Joseph Francis ; et al.	2014-01-16
Forms of [R-(R,R)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-meth- ylethyl)-3-phenyl-4-[(phenylmino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) Grant 8,563,750 - Park , et al. October 22, 2	2013-10-22
Novel Forms of [R-(R,R)]-2-(4-fluorophenyl)-beta,delta-Dihydroxy-5-(1-Methylethyl)-3-P- henyl-4-[(Phenylmino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20110301358 - Krzyzaniak; Joseph F. ; et al.	2011-12-08
Forms of [R-(R,R)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-meth- ylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoicacid calcium salt (2:1) Grant 8,026,376 - Krzyzaniak , et al. September 27, 2	2011-09-27
Hydrocodone polymorphs Grant 7,625,918 - Hagen , et al. December 1, 2	2009-12-01
Oxycodone polymorphs Grant 7,534,888 - Calderon , et al. May 19, 2	2009-05-19
CRYSTALS OF (2-AMINO-4,5,6,7-TETRAHYDROBENZO[b]THIEN-3-YL)(4-CHLOROPHENYL)METHANONE App 20090023799 - Laurence; George ; et al.	2009-01-22
Novel Succinate Salt of O-Desmethyl-Venlafaxine App 20090018208 - Hadfield; Anthony F. ; et al.	2009-01-15
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-P- henyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-HeptanoicAcid Calcium Salt (2:1) App 20080306282 - Krzyzaniak; Joseph F. ; et al.	2008-12-11
Crystalline Forms Of [R-(R,R)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1) App 20080287521 - Byrn; Stephen Robert ; et al.	2008-11-20
Crystalline forms of [R-(R, R)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- -[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) App 20080214651 - Byrn; Stephen Robert ; et al.	2008-09-04
Oxycodone polymorphs App 20070197572 - Calderon; Abram ; et al.	2007-08-23
Hydrocodone polymorphs App 20070072889 - Hagen; Eric J. ; et al.	2007-03-29
Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- -3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) Grant 7,144,915 - Byrn , et al. December 5, 2	2006-12-05
Crystalline forms of [R-(R.R)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-p- henyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) App 20060241169 - Park; Aeri	2006-10-26
Novel succinate salt of O-desmethyl-venlafaxine App 20050096479 - Hadfield, Anthony F. ; et al.	2005-05-05
Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5- -(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) App 20040054193 - Byrn, Stephen Robert ; et al.	2004-03-18
Novel succinate salt of O-desmethyl-venlafaxine App 20040044241 - Hadfield, Anthony F. ; et al.	2004-03-04
Succinate salt of O-desmethyl-venlafaxine Grant 6,673,838 - Hadfield , et al. January 6, 2	2004-01-06
Crystalline forms of [R-(R,R)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) Grant 6,605,729 - Byrn , et al. August 12, 2	2003-08-12
Novel succinate salt of O-desmethyl-venlafaxine App 20030045583 - Hadfield, Anthony F. ; et al.	2003-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.